Future Health Featured Articles

Future Health articles are available to CHR donors. To become a donor or to subscribe to the quarterly see Support/Subscribe.

  • Metformin, the most widely used drug to treat type 2 diabetes, could potentially be used to treat symptoms of Fragile X syndrome, an inherited form of intellectual disability and a cause of some forms of autism.

    A new study led by researchers at Université de Montréal, McGill University and the University of Edinburgh has found that metformin improves social, behavioural and...

  • An international team of researchers from the University of Rome Tor Vergata and the University of Montreal has reported, in a paper published in Nature Communications, the design and synthesis of a nanoscale molecular slingshot made of DNA that is 20,000 times smaller than a human hair.

    This molecular slingshot could “shoot” and deliver drugs at precise locations in...

  • A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that may cause 15% of adult alcohol- and tobaccolinked throat cancers. The researchers are hopeful that the discovery, a first in the field of epigenetics, will blaze a path to the development of new, targeted, more effective treatments over the next few years...

  • Scientists have identified a gene in the French-Canadian population that predisposes them to the development of intracranial aneurysm (IA), a potentially life threatening neurological condition that is responsible for approximately 500,000 deaths worldwide per year, half of which occur in people less than 50 years of age.

    Using genetic analysis, the team of researchers found rare...

  • CHR remains in the midst of a major administrative transition as the management of the office is being prepared for outsourcing to the Toronto-based firm Absolute Events. This move is expected to be a cost-effective approach to maintaining internal operations,
    while not in any way altering the organization’s familiar presence and activities for its donors and the public. Absolute Events...

  • Groundbreaking research from the University of Alberta and McGill University has opened the door towards the future prevention of cardiac fibrosis — a condition leading to heart failure, for which there is currently no treatment.

    The collaborative study, funded by the Canadian Institutes of Health Research and published in PLOS One, examined the molecular mechanisms that lead...

  • Researchers from Polytechnique Montréal, Université de Montréal and McGill University have achieved a spectacular breakthrough in cancer research. They have developed new nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision by specifically targeting active cancerous tumour cells. This way of injecting medication ensures optimal targeting of...

  • Scientists at the Montreal Neurological Institute and Hospital at McGill University have made an important discovery about the human auditory system and how to study it. These findings could lead to better testing and diagnosis of hearing-related disorders.

    The researchers detected frequency-following responses (FFR) coming from a part of the brain not previously known to emit them....

  • The 2016 Sanofi Pasteur Medal of Excellence in Health Research Journalism was awarded in June as part of the Annual General Meeting of the Canadian Science Writers’ Association, which was held at the University of Guelph in Guelph, ON.

    Although this year’s winner, Quebec Science writer Marine Corniou, could not attend, CHR board chair Tim Lougheed described her accomplishment for the...

Pages